Cargando…
Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters—a randomized, double‐blind, placebo‐controlled trial
OBJECTIVE: To evaluate the safety and efficacy of a novel formulation of midazolam administered as a single‐dose nasal spray (MDZ–NS) in the outpatient treatment of patients experiencing seizure clusters (SCs). METHODS: This was a phase III, randomized, double‐blind, placebo‐controlled trial (Clinic...
Autores principales: | Detyniecki, Kamil, Van Ess, Peter J., Sequeira, David J., Wheless, James W., Meng, Tze‐Chiang, Pullman, William E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291143/ https://www.ncbi.nlm.nih.gov/pubmed/31140596 http://dx.doi.org/10.1111/epi.15159 |
Ejemplares similares
-
Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy
por: Wheless, James W., et al.
Publicado: (2021) -
Consistent safety and tolerability of Valtoco(®) (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study
por: Miller, Ian, et al.
Publicado: (2021) -
Premedication With Midazolam Nasal Spray: An Alternative to Oral Midazolam in Children
por: Verma, Ravi K, et al.
Publicado: (2012) -
The Evaluation of the Efficacy and Safety of Midazolam Nasal Spray in Patients With Seizure Clusters: A Systematic Review and Meta-Analysis
por: Niraj, Niraj, et al.
Publicado: (2023) -
Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study
por: Segal, Eric B., et al.
Publicado: (2021)